← Leaderboards
Parvin Yazdani-Kachooei
Baylor College Of Medicine
$57,322
Attributed
$57,322
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $11.3K · FY2005–11$20K$15K$10K$5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$57,322 · 6
By mechanism
M01$57,322 · 6
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Teresia Margareta O'Connor$6,721,651
- William Thomas Shearer$34,592,326
- Melissa Anne Suter$1,235,409
- Steven A Abrams$3,766,448
- Helen E Heslop$25,308,937
Others in their field
Top investigators on “Thyroxine”
- Joseph S Takahashi · University Of Chicago$22,466,198
- Brenda Eskenazi · University Of California Berkeley$11,267,159
- Philip Reed Larsen · Brigham And Women'S Hospital$10,845,311
- Antonio C Bianco · University Of Chicago$7,284,688
- Thomas Sterling Scanlan · University Of California San Francisco$7,049,531
- Anne R Cappola · University Of Maryland Baltimore$5,897,972
Research focus
ThyroxineSomatotropinHypothyroidismAgonistUnited States National Institutes Of HealthAdolescentAdultCohortFailure (Biologic Function)FundingGrantGrowthHeightLong-Term EffectsRandomizedResourcesSourceResearch PersonnelClinical TrialsComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionClinical Research11 Year OldOutcome Forecast
Grant awards (8)
CLINICAL TRIAL: GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HY$7,519
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HY$10,682
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HY$11,258
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HY$7,808
M01 · FY2008 · RR · contact PI
GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HYPOTHYROIDISM$7,908
M01 · FY2007 · RR · contact PI
GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HYPOTHYROIDISM$5,273
M01 · FY2006 · RR · contact PI
GROWTH HORMONE AND GNRH AGONIST IN ADOLESCENTS WITH ACQUIRED HYPOTHYROIDISM$5,171
M01 · FY2005 · RR
Growth Hormone /GNRH Agonist in Adolescents with Acquire$1,703
M01 · FY2004 · RR